Insulin Doctor: This Is The First Sign Of Dementia! The Shocking Link Between Keto & Brain Decline!
No.1 Keto Doctor DR. ANNETTE BOSWORTH reveals how to reverse insulin resistance, cut belly fat, avoid early dementia, why eating late spikes glucose, and the sardine-only reset for ketosis. Dr Annette Bosworth, commonly known as Dr Boz, is an internal medicine doctor with over 2 decades of experience, who helps reverse medical problems through healthy […]
Shaily Engineering shares up 3%; UBS initiates buy with 60% upside potential
UBS has initiated coverage on Shaily Engineering Plastics with a Buy rating and a target price of Rs 4,000, citing strong growth prospects driven by its patented technology, upcoming GLP-1 generic launch, and improving utilisation across consumer and industrial segments. The brokerage expects robust earnings growth and market share gains supported by high entry barriers […]
Study finds GLP-1 drugs improve strength and reverse aging biology in mice
Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight. These benefits depended largely on hypothalamic GLP-1R signaling and closely mirrored the anti-aging patterns produced by rapamycin.
Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s?
The Trump administration’s new deal lowers prices and expands access to GLP-1 drugs, but experts argue far broader reforms are needed to address high prescription drug costs overall. The post Could Trump do for Branded Expensive Drugs What He Just Did for GLP-1s? appeared first on MedCity News.
Better Than Ozempic? New Oxytocin Combination Could Eliminate Side Effects
In addition to reducing hunger, popular weight-loss drugs also affect reward processing and motivated behaviors. New research is offering a clearer picture of how medications that target the glucagon-like peptide-1 (GLP-1) system influence brain networks involved in nausea, thirst, and reward-driven behaviors. These new results were recently shared at Neuroscience 2025, the annual meeting of […]
Eli Lilly to Launch a GLP-1 Pill to Rival Ozempic, but There’s a Catch
The new drug will target weight loss for people with obesity and type 2 diabetes.
Daily oral GLP-1 pill a promising alternative to injectables for weight loss, clinical trial finds
A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.
JCM, Vol. 14, Pages 8326: Diabetes Mellitus and Chronic Kidney Disease: The Future Is Being Surpassed
JCM, Vol. 14, Pages 8326: Diabetes Mellitus and Chronic Kidney Disease: The Future Is Being Surpassed Journal of Clinical Medicine doi: 10.3390/jcm14238326 Authors: Alberto Martínez-Castelao José Luis Górriz Beatriz Fernández-Fernández María José Soler Juan F. Navarro-González Diabetes mellitus (DM) continues to be a global world health problem. Despite medical advances, both DM and chronic kidney […]
Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1 – Seeking Alpha
Can Novo unravel Lilly rally with Alzheimer’s data for GLP-1 Seeking Alpha High-stakes Novo Nordisk Alzheimer’s studies could yield answers on GLP-1 benefit Reuters Can GLP-1 drugs treat Alzheimer’s? Novo Nordisk will soon announce key results statnews.com Key facts: Novo Nordisk trials Rybelsus for cognitive decline; analysts see stable growth TradingView Novo Nordisk Will Soon Reveal Whether Its GLP-1 […]
Novo Launches Studies to See Whether GLP-1 Drugs Can Slow Alzheimer’s
Post Content